Skip to content

Skin Cancer Diagnostics Using Photoacoustic Imaging

Photoacoustic Imaging for Three-dimensional Delineation of Skin Tumors

Status
Suspended
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06379581
Enrollment
200
Registered
2024-04-23
Start date
2023-01-01
Completion date
2027-10-01
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Cancer

Brief summary

In this clinical study, photoacoustic imaging will be used on patients with suspected skin cancer (primarily melanoma, basal cell carcinoma, and squamous cell carcinoma) to determine the tumor borders both superficially and at a depth.

Detailed description

The study will employ multispectral photoacoustic imaging in the spectral range between 680-970 nm to scan suspected skin tumors both in vivo and ex vivo. The hyperspectral data will then undergo rigorous spectral analysis with the objective to identify the spectral fingerprints associated with healthy tissue and tumor. Thereafter, a classification algorithm will be used to determine whether a pixel in the acquired image more likely identifies with healthy tissue or tumor, which is then repeated for all pixels in the images. As such, a 3D image can be reconstructed in which the tumor is visibly contrasted from healthy tissue. Achieving this goal will facilitate the diagnostic procedures and greatly reduce waiting times, clinical costs and potential patient suffering.

Interventions

None listed

Sponsors

Region Skane
Lead SponsorOTHER
Lund University
CollaboratorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to perform surgical excision of lesion(s) suspected to be tumors.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Tumor thicknessEnrollment is anticipated to last 1 year + final analyse 6 monthsCompare the estimated tumor thickness of tumor lesion with the provided thickness from the histopathological investigation.
Tumor sizeEnrollment is anticipated to last 1 year + final analyse 6 monthsCompare the estimated tumor surface size of tumor lesion with the provided thickness from the histopathological investigation.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026